Hunan Er Kang Pharmaceutical Capital Reinvestment Ratio
Hunan Er Kang Pharmaceutical capital reinvestment ratio. Hunan Er Kang Pharmaceutical (300267) has a Capital Reinvestment Ratio of 0.26x as of June 2023, meaning it reinvests 0% of its operating cash flow (CN¥174.55 Million) in capital expenditures (CN¥45.68 Million). Check cash flow reinvestment rate of Hunan Er Kang Pharmaceutical to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Hunan Er Kang Pharmaceutical (2008–2024)
Capital reinvestment ratio of Hunan Er Kang Pharmaceutical from 2008 to 2024. This chart tracks Hunan Er Kang Pharmaceutical's Capital Reinvestment Ratio across 17 annual periods. Also explore net asset growth rate of Hunan Er Kang Pharmaceutical to track the company's year-over-year net asset growth rate.
Hunan Er Kang Pharmaceutical Capital Reinvestment Ratio by Year (2008–2024)
Hunan Er Kang Pharmaceutical capital reinvestment ratio by year from 2008 to 2024. For the full cash flow conversion analysis, see cash flow conversion of Hunan Er Kang Pharmaceutical.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.17x | CN¥166.69 Million | CN¥195.60 Million | ▼ -26.9% |
| 2023 | 1.60x | CN¥148.42 Million | CN¥238.19 Million | ▲ +159.9% |
| 2022 | 0.62x | CN¥281.02 Million | CN¥173.49 Million | ▼ -83.6% |
| 2021 | 3.77x | CN¥92.68 Million | CN¥349.33 Million | ▲ +11.1% |
| 2020 | 3.39x | CN¥178.53 Million | CN¥605.89 Million | ▲ +315.4% |
| 2019 | 0.82x | CN¥445.82 Million | CN¥364.21 Million | ▲ +4.6% |
| 2018 | 0.78x | CN¥123.89 Million | CN¥96.72 Million | ▲ +107.8% |
| 2017 | 0.38x | CN¥689.11 Million | CN¥258.92 Million | ▼ -84.0% |
| 2016 | 2.36x | CN¥486.50 Million | CN¥1.15 Billion | ▲ +114.2% |
| 2015 | 1.10x | CN¥518.96 Million | CN¥570.53 Million | ▼ -63.4% |
| 2014 | 3.01x | CN¥175.38 Million | CN¥527.42 Million | ▲ +156.9% |
| 2013 | 1.17x | CN¥174.22 Million | CN¥203.98 Million | ▼ -57.5% |
| 2012 | 2.75x | CN¥84.02 Million | CN¥231.28 Million | ▲ +375.1% |
| 2011 | 0.58x | CN¥75.72 Million | CN¥43.87 Million | ▼ -62.2% |
| 2010 | 1.53x | CN¥42.47 Million | CN¥65.05 Million | ▼ -20.6% |
| 2009 | 1.93x | CN¥10.18 Million | CN¥19.64 Million | ▼ -96.8% |
| 2008 | 59.81x | CN¥211.00K | CN¥12.62 Million | — |